Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

1. Rubboli, A, Schlitt, A, Kiviniemi, T, et al. One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry. Clin Cardiol. 2014;37(6):357-364.
Google Scholar | Crossref | Medline2. Paikin, JS, Wright, DS, Crowther, MA, Mehta, SR, Eikelboom, JW. Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents. Circulation. 2010;121(18):2067–2070.
Google Scholar | Crossref | Medline3. Dewilde, WJ, Oirbans, T, Verheugt, FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary invertvention: an open-label, randomise, controlled trial (WOEST). Lancet. 2013;381(9872):1107–1115.
Google Scholar | Crossref | Medline | ISI4. Fiedler, KA, Maeng, M, Mehilli, J, et al. Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial. J Am Coll Cardiol. 2015;65(16):1619–1629.
Google Scholar | Crossref | Medline | ISI5. Wiviott, SD, Braunwald, E, McCabe, CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes (TRITON-TIMI 38). N Engl J Med. 2007;357:2001–2015.
Google Scholar | Crossref | Medline | ISI6. Wallentin, L, Becker, RC, Budaj, A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes (PLATO). N Engl J Med. 2009;361:1045–1057.
Google Scholar | Crossref | Medline | ISI7. Gibson, CM, Mehran, R, Bode, C, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI (PIONEER AF-PCI). N Engl J Med. 2016;375(25):2423–2434.
Google Scholar | Crossref | Medline8. Mehran, R, Rao, SV, Bhatt, DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 2011;123(23):2736–2747.
Google Scholar | Crossref | Medline | ISI9. Angiolillo, DJ, Bhatt, DL, Cannon, CP, et al. Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a north American perspective—2021 Update. Circulation. 2021;143(6):583–596.
Google Scholar | Crossref | Medline10. January, CT, Wann, S, Calkins, H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140:e125–e151.
Google Scholar | Crossref | Medline11. Valgimigli, M, Bueno, H, Byrne, RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018 Jan 14;39(3):213–260.
Google Scholar | Crossref | Medline12. Kumbhani, DJ, Cannon, CP, Beavers, CJ, et al. 2020 ACC Expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2021;77(5):629–658.
Google Scholar | Medline13. Cannon, CP, Bhatt, DL, Oldgren, J, et al. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation (RE-DUAL PCI). N Engl J Med. 2017;377(16):1513–1524.
Google Scholar | Crossref | Medline14. Lopes, RD, Heizer, G, Aronson, R, et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation (AUGUSTUS). N Engl J Med. 2019;380(16):1509–1524.
Google Scholar | Crossref | Medline15. Alexander, JH, Wojdyla, D, Vora, AN, et al. Risk/Benefit tradeoff of antithrombotic therapy in patients with atrial fibrillation early and late after an acute coronary syndrome or percutaneous coronary intervention. Circulation. 2020;141(20):1618–1627.
Google Scholar | Crossref | Medline16. Fu, A, Singh, K, Abunassar, J, et al. Ticagrelor in triple antithrombotic therapy: predictors of ischemic and bleeding complications. Clin Cardiol. 2016;39(1):19–23.
Google Scholar | Crossref | Medline17. Lupercio, F, Giancaterino, S, Villablanca, PA, et al. P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis. Heart 2020;106(8):575–583.
Google Scholar | Crossref | Medline18. Andreou, I, Briasoulis, A, Pappas, C, et al. Ticagrelor versus clopidogrel as part of dual or triple antithrombotic therapy: a systematic review and meta-analysis. Cardiovasc Drugs Ther. 2018 Jun;32(3):287–294.
Google Scholar | Crossref | Medline19. Le May, MR, Acharya, S, Wells, GE, et al. Prophylactic warfarin therapy after primary percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. JACC: Cardiovasc Interv. 2015;8(1):155–162.
Google Scholar | Crossref | Medline20. Moulson, N, laHaye, SA, Vertrand, OF, MacHaalany, J. Prophylactic warfarin post anterior ST-elevation myocardial infarction: a systematic review and meta-analysis. Cardiovasc Revasc Med. 2017;18(8):559–564.
Google Scholar | Crossref | Medline21. Shavadia, JS, Yougson, E, Bainey, KR, Bakal, J, Welsh, RC. Outcomes and prognostic impact of prophylactic oral anticoagulation in anterior ST-segment elevation myocardial infarction patients with left ventricular dysfunction. J Am Heart Assoc. 2017;6(7):e006054. doi:10. 1161/JAHA.117.006054
Google Scholar | Crossref | Medline22. Mehta, SR, Bainey, KR, Cantro, WJ, et al. 2018 Canadian Cardiovascular Society/Canadian Association of Intervention Cardiology focused update of the guidelines for the use of antiplatelet therapy. Can J Cardiol. 2018;34(3):214–233.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif